IU School of Medicine received FDA clearance for a blood test detecting amyloid plaques in Alzheimer’s disease through phosphorylated tau biomarkers. A novel artificial pancreas technology using digital twins improved glycemic control in type 1 diabetes patients. UC San Diego researchers identified accelerated biological aging markers in pediatric multiple sclerosis. Innovative therapies and diagnostic platforms targeting metabolic disorders, functional neurology, and related diseases continue to emerge, setting new standards for disease management and personalized medicine.